Orioles officially announce signing of Suk-min Yoon

5 Comments

The Orioles officially announced the signing of South Korean right-hander Suk-min Yoon this afternoon. As it was reported late last week, he agreed to a three-year, $5.75 million contract.

The pre-signing physical was the last thing standing in the way of the deal becoming official today. And that has been anything but a formality with the Orioles this winter, as deals with Grant Balfour and Tyler Colvin were both nixed due to issues raised during their physical exams. However, Yoon apparently checked out just fine, even though he dealt with some shoulder issues last season.

Here’s an announcement from Orioles executive vice president Dan Duquette:

“We are excited to bring Suk-min Yoon to the organization. He has been a top pitcher in the Korea Baseball Organization and has pitched successfully in international competition. We look forward to his contributions to the Orioles.”

Yoon, 27, posted a 3.19 ERA over nine seasons with the KIA Tigers of the Korean Baseball Organization and took home Most Valuable Player honors in 2011. He saw his performance and velocity drop off after participating in the World Baseball Classic last year, posting a 4.00 ERA and a 76/28 K/BB ratio in 87 2/3 innings between the rotation and the bullpen. It’s not clear yet how the Orioles intend to use him.

Red Sox shut down David Price for remainder of season

Jim McIsaac/Getty Images
Leave a comment

Red Sox manager Alex Cora said that starter David Price has been shut down for the remainder of the season during Wednesday’s appearance on WEEI’s Ordway, Merloni, and Fauria.

Price, 34, missed nearly a month between August 5-31 with a wrist injury (TFCC cyst). He returned on September 1, but lasted only two innings against the Angels and hasn’t pitched since.

Price ends a disappointing 2019 season with a 4.28 ERA and a 128/32 K/BB ratio in 107 1/3 innings across 22 starts. He’ll enter the fifth year of his seven-year, $217 million contract in 2020. $96 million remains on the deal.